Mammograms, On Cancer Blog, Drug Costs, and Recognition for Three SKI Researchers

Here are a few worthy news items about MSK staff:

  • From the MSK On Cancer Blog, Immunologist Alexander Rudensky discusses new approaches for treating cancer.

Breast Cancer, Immunotherapy, and Cancer Care Outcomes

Surfing the web retrieved these selected informational items:

  • A series of comments regarding an essay entitled “The Breast Cancer Gene and Me” (NY Times Sunday Review, Sep 27) included one by Dr. Kenneth Offit, Chief, Clinical Genetics Service from MSK.

Partnerships, New Treatment, and a Thomson Reuters Citation Laureate

While browsing the news, these are some of the stories that rose to the top!

  • Cornell University in partnership with Memorial Sloan Kettering is opening a new $10 million Center of Cancer Nanotechnology Excellence, bringing together scientists, engineers, biologists, and physicians to develop and translate new cancer care applications based on nanotechnology.
  • Collaborative enterprise announced between Memorial Sloan Kettering and Illumina, Inc. to conduct research studies critical to understanding the biology of circulating tumor DNA (ctDNA). The studies aim to inform the development of new strategies to diagnose and monitor cancer and to help establish ctDNA as an important marker in the study and eventual treatment of cancer. Dr. Jose Baselga, Physician-in-Chief and Chief Medical Officer, Memorial Hospital is quoted.

Continue reading